| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Metagenomi, Inc. (MGX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.51M | $3.57M | - | |
| CEO | 563.8K | $800.7K | - | |
| CFO | 189.0K | $268.3K | - | |
| Other | 115.0K | $163.3K | - | |
| Other | 109.1K | $155.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Thomas Brian C.48 | Director | Sell | 3,830 | $1.77 | $6,786.38 | -0.2% | -9.6% | - | |
| Dec 5, 2025 | Wein Matthew65 | See Remarks | Sell | 199 | $1.77 | $352.61 | -0.2% | -9.6% | - | |
| Dec 5, 2025 | Wapnick Pamela69 | Chief Financial Officer | Sell | 1,576 | $1.77 | $2,792.51 | -0.8% | -9.6% | - | |
| Dec 5, 2025 | Irish Jian48 | Chief Executive Officer | Sell | 1,602 | $1.77 | $2,838.58 | -0.3% | -9.6% | - | |
| Sep 5, 2025 | Thomas Brian C.48 | Director | Sell | 2,701 | $1.81 | $4,888.81 | -0.1% | -6.3% | - | |
| Sep 5, 2025 | Wapnick Pamela69 | Chief Financial Officer | Sell | 1,576 | $1.81 | $2,852.56 | -2.2% | -6.3% | - | |
| Sep 5, 2025 | Irish Jian48 | Chief Executive Officer | Sell | 1,602 | $1.81 | $2,899.62 | -0.5% | -6.3% | - | |
| Sep 5, 2025 | Wein Matthew65 | See Remarks | Sell | 199 | $1.81 | $360.19 | -1.0% | -6.3% | - | |
| Jun 6, 2025 | Wein Matthew65 | See Remarks | Sell | 199 | $1.75 | $348.25 | -1.2% | +2.9% | - | |
| Jun 6, 2025 | Noonberg Sarah B. | Chief Medical Officer | Sell | 5,239 | $1.75 | $9,168.25 | -4.6% | +2.9% | - |